CorMedix (CRMD) Current Leases (2019 - 2025)
CorMedix's (CRMD) quarterly Current Leases came in at $853000.0 in Q4 2025, up 407.74% year-on-year from $168000.0 in Q4 2024, and up 47.28% quarter-over-quarter from $579168.0 in Q3 2025.
CorMedix (CRMD) Current Leases (2019 - 2025) Analysis & Trends
CorMedix has disclosed Current Leases across 7 years of filings, most recently posting $853000.0 for Q4 2025.
- Current Leases for Q4 2025 came in at $853000.0, up 407.74% year-over-year; the trailing twelve-month figure through Dec 2025 was $853000.0 (up 407.74% YoY), and the FY2025 annual result was $853000.0, up 407.74% from the prior year.
- Current Leases came in at $853000.0 for Q4 2025 at CorMedix, up from $579168.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $853000.0 in Q4 2025 to a low of $112323.0 in Q1 2021.
- The 5-year median for Current Leases is $144532.0 (2023), against an average of $199557.6.
- Across the five-year window, Current Leases grew 10.22% in 2022 and jumped 407.74% in 2025, its largest moves.
- CorMedix's Current Leases stood at $121368.0 in 2021, then advanced by 11.23% to $135000.0 in 2022, then advanced by 11.85% to $151000.0 in 2023, then rose by 11.26% to $168000.0 in 2024, then surged by 407.74% to $853000.0 in 2025.
- The last three Current Leases figures came in at $853000.0 (Q4 2025), $579168.0 (Q3 2025), and $177172.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 853,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 853,000.00 |
| Sep 30, 2025 | 579,168.00 |
| Jun 30, 2025 | 177,172.00 |
| Mar 31, 2025 | 172,495.00 |
| Dec 31, 2024 | 168,000.00 |
| Sep 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 159,077.00 |
| Mar 31, 2024 | 155,000.00 |
| Dec 31, 2023 | 151,000.00 |
| Sep 30, 2023 | 146,531.00 |
| Jun 30, 2023 | 142,533.00 |
| Mar 31, 2023 | 138,623.00 |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | 131,063.00 |
| Jun 30, 2022 | 127,408.00 |
| Mar 31, 2022 | 124,354.00 |
| Dec 31, 2021 | 121,368.00 |
| Sep 30, 2021 | 118,447.00 |
| Jun 30, 2021 | 115,590.00 |
| Mar 31, 2021 | 112,323.00 |